Figure 3. Receiver operating characteristics analysis for the baseline mature PCSK9 (proprotein convertase subtilisin/kexin) level to predict a hyporesponse to a statin (defined as percent reduction of low‐density lipoprotein cholesterol <15%).

AUC indicates area under the curve.